StonvexLoading…
StonvexStonvexStonvexCore line items from ALGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-27 | Annual 2025 2025-03-28 | Annual 2024 2024-03-29 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $890.10M | $725.01M | $1.05B | $973.65M |
Operating Income | $18.49M | $-19.80M | $196.24M | $203.31M |
Net Income | $-14.90M | $-73.01M | $152.70M | $187.36M |
EPS (Diluted) | $-0.08 | $-0.39 | $0.78 | $0.97 |
Total Assets | $1.42B | $1.42B | $1.53B | $1.18B |
Total Liabilities | $459.73M | $489.86M | $398.89M | $214.34M |
Cash & Equivalents | $168.75M | $121.33M | $212.14M | $351.58M |
Free Cash Flow OCF − CapEx | $124.89M | $21.96M | $56.94M | $113.43M |
Shares Outstanding | 185.36M | 184.29M | 193.16M | 191.75M |